ALVO
NASDAQ · Biotechnology
Alvotech Sa
$3.81
+0.01 (+0.26%)
Analyst Consensus
Buy
11
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+732.5% upside
Low Target
$22.31
Average Target
$31.72
High Target
$46.94
Current Price
$3.81
Current
$3.81
$3.81
Target
$31.72
$31.72
$22.31
$31.72 avg
$46.94
Scenario Analysis
Bear Case
$22.31
485.6%
Low target
Base Case
$31.72
+732.5%
Avg target
Bull Case
$46.94
+1,132.0%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$9.25
-58.8% from high
52-Week Low
$2.94
+29.6% from low
Target vs 52W High
$31.72
+242.9% vs high
Next Earnings Report
Aug 19, 2026
10d
until earnings
EPS Est: $-0.03
Earnings in 10 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 79% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 40 | 83% | $438.34 | -11.6% |
| REGN | Buy | 38 | 71% | $76.80 | -90.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.6% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -44.4% |
| BIIB | Buy | 44 | 64% | $91.45 | -56.0% |